Scoring evaluation of the natural course of mucopolysaccharidosis type IIIA (Sanfilippo syndrome type A)
- PMID: 17938166
- DOI: 10.1542/peds.2007-0282
Scoring evaluation of the natural course of mucopolysaccharidosis type IIIA (Sanfilippo syndrome type A)
Abstract
Objective: Mucopolysaccharidosis types IIIA through IIID (Sanfilippo syndrome) are caused by deficiencies of enzymes involved in the degradation of heparan sulfate. The onset and severity of the disease are highly variable. The purpose of this study was to describe the natural course of mucopolysaccharidosis type IIIA in a large cohort of patients.
Patients and methods: The natural course of mucopolysaccharidosis type IIIA was assessed in 71 patients by using a detailed questionnaire and a 4-point scoring system and compared with the course of the disease in 14 patients with mucopolysaccharidosis type IIIB and 4 patients with mucopolysaccharidosis type IIIC.
Results: In the cohort of patients with mucopolysaccharidosis type IIIA, first symptoms of disease were observed, on average, at 7 months of age. Speech and motor development were delayed in 66.2% and 33.9% of patients, respectively. The median age at diagnosis was 4.5 years. The onset of regression in speech, motor, and cognitive function was observed at an average age of 3.3 years. The loss of all 3 of the assessed abilities was observed at an average age of 12.5 years. Speech was lost before motor and cognitive functions. In a small group of patients who were >12.5 years of age (9.9%), speech, motor, and cognitive skills were partially preserved up to a maximum age of 23.8 years.
Conclusions: To our knowledge, this is the first systematic and comprehensive study on the natural course of mucopolysaccharidosis type IIIA. The 4-point scoring system may be used to classify patients into groups with a rapid or slower course of the disease. This may have an important impact on parental counseling as well as therapeutic interventions.
Similar articles
-
The mutation p.Ser298Pro in the sulphamidase gene (SGSH) is associated with a slowly progressive clinical phenotype in mucopolysaccharidosis type IIIA (Sanfilippo A syndrome).Hum Mutat. 2008 May;29(5):770. doi: 10.1002/humu.20738. Hum Mutat. 2008. PMID: 18407553
-
Mucopolysaccharidosis type III (Sanfilippo disease) in Sweden: clinical presentation of 22 children diagnosed during a 30-year period.Acta Paediatr. 2010 Aug;99(8):1253-7. doi: 10.1111/j.1651-2227.2010.01800.x. Epub 2010 Mar 14. Acta Paediatr. 2010. PMID: 20337777
-
Spinal muscular atrophy: survival pattern and functional status.Pediatrics. 2004 Nov;114(5):e548-53. doi: 10.1542/peds.2004-0668. Epub 2004 Oct 18. Pediatrics. 2004. PMID: 15492357
-
Is Sanfilippo type B in your mind when you see adults with mental retardation and behavioral problems?Am J Med Genet C Semin Med Genet. 2007 Aug 15;145C(3):293-301. doi: 10.1002/ajmg.c.30142. Am J Med Genet C Semin Med Genet. 2007. PMID: 17640047 Review.
-
[Hyperactivity and behavioral disorders in Sanfilippo A (mucopolysaccharidosis type IIIA)--case report and review of the literature].Psychiatr Pol. 2000 Sep-Oct;34(5):831-7. Psychiatr Pol. 2000. PMID: 11202024 Review. Polish.
Cited by
-
The Role of the Gut Microbiota in Sanfilippo Syndrome's Physiopathology: An Approach in Two Affected Siblings.Int J Mol Sci. 2024 Aug 14;25(16):8856. doi: 10.3390/ijms25168856. Int J Mol Sci. 2024. PMID: 39201540 Free PMC article.
-
Assessment of sleep in children with mucopolysaccharidosis type III.PLoS One. 2014 Feb 4;9(2):e84128. doi: 10.1371/journal.pone.0084128. eCollection 2014. PLoS One. 2014. PMID: 24504123 Free PMC article.
-
Hematopoietic stem cell transplantation in mucopolysaccharidosis type IIIA: A case description and comparison with a genotype-matched control group.Mol Genet Metab Rep. 2020 Mar 23;23:100578. doi: 10.1016/j.ymgmr.2020.100578. eCollection 2020 Jun. Mol Genet Metab Rep. 2020. PMID: 32226768 Free PMC article.
-
Electrophysiological and Histological Characterization of Rod-Cone Retinal Degeneration and Microglia Activation in a Mouse Model of Mucopolysaccharidosis Type IIIB.Sci Rep. 2015 Nov 26;5:17143. doi: 10.1038/srep17143. Sci Rep. 2015. PMID: 26607664 Free PMC article.
-
Ataxia is the major neuropathological finding in arylsulfatase G-deficient mice: similarities and dissimilarities to Sanfilippo disease (mucopolysaccharidosis type III).Hum Mol Genet. 2015 Apr 1;24(7):1856-68. doi: 10.1093/hmg/ddu603. Epub 2014 Dec 1. Hum Mol Genet. 2015. PMID: 25452429 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical